Brief: TheraVet Announces Positive Results For VISCO-VET In Canine Osteoarthritis

Theravet SA

08/09/2021 06:34

Sept 8 (Reuters) - THERAVET SA  ALVET.PA :
    * THERAVET ANNOUNCES POSITIVE SAFETY AND EFFICACY RESULTS
FOR
VISCO-VET IN CANINE OSTEOARTHRITIS
    * STATISTICALLY SIGNIFICANT IMPROVEMENT OF DOG'S MOBILITY
    * EFFECTS LASTING (AND INCREASING OVER) UP TO 3 MONTHS AFTER
INJECTION
    * STATISTICALLY SIGNIFICANT REDUCTION OF DOG'S
OSTEOARTHRITIS-RELATED PAIN
    * WELL TOLERATED WITH NO ADVERSE EVENT REPORTED
    * POSITIVE SAFETY AND EFFICACY RESULTS OF ITS POC
(PROOF-OF-CONCEPT) CLINICAL STUDY
    * TOGETHER, RESULTS OF THIS POC STUDY DEMONSTRATE LONG
LASTING AND
STATISTICALLY SIGNIFICANT EFFECTS OF VISCO-VET IN IMPROVING
MOBILITY AND IN REDUCING PAIN IN DOGS WITH OSTEOARTHRITIS FOR UP
TO 3 MONTHS AFTER A SINGLE INTRA-ARTICULAR INJECTION
    * SIMILAR LEVELS OF OA-RELATED PAIN REDUCTION WERE REPORTED
WITH
OA REGISTERED MEDICATIONS BUT THESE EFFECTS WERE LIMITED TO 28
DAYS (APPROVED TREATMENT DURATION), WHILE THEY WERE LASTING AT
LEAST FOR 3 MONTHS WITH VISCO-VET AFTER A SINGLE INTRA-ARTICULAR
INJECTION
    * IMPROVEMENTS WERE ALREADY OBSERVED AT 1 AND 2 MONTHS
(RESPECTIVELY, -15.7% (P>0.05) AND -21.8% (P<0.05)),
DEMONSTRATING INCREASE IN EFFICACY OF VISCO-VET OVER TIME AND
ITS LONG-TERM EFFECT ON DOG'S MOBILITY

Source text for Eikon:  ID:nBw6ytJZFa 
Further company coverage:  ALVET.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))